Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-25 Purchase |
2024-11-25 8:30 pm |
Kairos Pharma LTD. | KAPA | Murali Ramachandran VP of Research and Development |
200 | $1.59 | $318 | 133,057 (Direct) |
View |
| 2024-11-22 Purchase |
2024-11-25 06:03 am |
Kairos Pharma LTD. | KAPA | Samuelson Doug Chief Financial Officer |
2,500 | $1.5 | $3,750 | 60,796 (Direct) |
View |
| 2024-11-20 Purchase |
2024-11-21 9:53 pm |
Kairos Pharma LTD. | KAPA | Yu John S CEO and Chairman 10% Owner |
4,000 | $1.44 | $5,760 | 5,341,837 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Option Award |
2025-04-07 08:30 am |
N/A N/A |
Kairos Pharma LTD. | KAPA | Bhowmick Neil Chief Scientific Officer |
14,000 | $0 | 1,139,983 (Direct) |
View |
| 2025-01-01 Option Award |
2025-02-24 6:52 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Murali Ramachandran VP of Research and Development |
14,000 | $0 | 147,057 (Direct) |
View |
| 2025-01-01 Option Award |
2025-02-24 6:51 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Yu John S CEO and Chairman 10% Owner |
14,000 | $0 | 5,355,838 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Bhowmick Neil Chief Scientific Officer |
0 | $0 | 1,125,983 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | MAZANET ROSEMARY Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Murali Ramachandran VP of Research and Development |
0 | $0 | 132,857 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Keyoung Hansoo Michael Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Samuelson Doug Chief Financial Officer |
0 | $0 | 58,296 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Yu John S CEO and Chairman 10% Owner |
0 | $0 | 5,337,837 (Direct) |
View |
Ownership |
2024-09-24 9:00 pm |
N/A N/A |
Kairos Pharma LTD. | KAPA | Bae Hyun W. Director |
0 | $0 | 44,286 (Direct) |
View |